stars 1 stars 2 stars 3

4C LABS is a rapidly scaling healthcare, technology and pharmaceutical start-up focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicinal products for human health. The empirical evidence for the efficacy of CBPM's as a therapeutic agent in the treatment of cancer related pain, anxiety, childhood epilepsy, spasticity and sleep disorders is now overwhelming. We are committed to advancing scientific research, as well as enabling the regulation, distribution and prescribing of CBPM's in the UK and Channel Islands. Our work with leading scientists, specialist physicians and pharmacists is underpinned with disruptive technologies that are driving an approach to treatment that prioritizes patients and evidence over stigma. We work closely with Drug Science, the Cannabis Industry Council, The Home Office, The Medicines and Healthcare and regulatory Authority and the Care Quality Commission to catalyse safe, regulated change in the medical landscape. If you are a technologist, physician, scientist, distributor, LP or a patient and are interested in working with us, get in touch for a conversation: info@4clabs.ca

4C LABS Questions

Gregory Dobbin is the CEO of 4C LABS.

16 people are employed at 4C LABS.

Top 4C LABS Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users